Fate Therapeutics Inc at Bank of America Healthcare Conference Transcript

May 12, 2022 / 04:20PM GMT
Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research Analyst

Good morning, everybody. Welcome back to the Bank of America Healthcare Conference. I'm Tazeen Ahmad. I'm one of the Senior SMID Biotech analyst at the bank. It is my pleasure to have our next presenting company here with us, Fate Therapeutics.

J. Scott Wolchko - Fate Therapeutics, Inc. - Founder, CEO, President & Director

Thank you.

Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research Analyst

Sitting next to me is CEO, Scott Wolchko. Scott, good morning. Thank you for coming (inaudible)

J. Scott Wolchko - Fate Therapeutics, Inc. - Founder, CEO, President & Director

Good morning. Thanks for having us. Nice to see you in person.

Tazeen Ahmad - BofA Securities, Research Division - MD in Equity Research & Research Analyst

Yes, for sure. So maybe you could start off by giving everybody a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot